Duration and onset of action of indacaterol, a novel 24-hour β2 -agonist, on isolated human bronchus Source: Eur Respir J 2005; 26: Suppl. 49, 216s Year: 2005
LAS100977, a novel β2 -agonist, has a longer duration of action and a more favourable therapeutic index than salmeterol in anaesthetised dogs Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
LAS100977 is a novel, potent β2 -agonist with rapid onset and sustained duration of action in vitro Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Alternative method to profile slow onset bronchodilators in guinea pig trachea in vitro for potency and pKB analysis Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004
The inhaled anticholinergic agent, aclidinium bromide, reverses cholinergic-induced bronchoconstriction in guinea pigs with a fast onset of action and a long duration of effect Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Assessment of the potency and duration of action of aclidinium bromide in guinea pig isolated trachea in vitro Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007
Effect of SMP-028, a novel anti-inflammatory agent, on experimental allergic asthma in guinea pig model Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
The bronchodilator effects of the novel anti-inflammatory compound TPI 1020, alone and in combination with formoterol, in conscious guinea pigs Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009
Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
AZD3199: A fast acting β2 -receptor agonist with a long duration of action Source: Annual Congress 2011 - Translational models of disease Year: 2011
Inhaled liposomal treprostinil (L606) shows extended release in healthy volunteer, as well as prolongs pharmacological effect in hypoxia-induced rat. Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020
Pathogenic effect of intratracheal exposure on nanocarbons - in vivo study on guinea pig model Source: Eur Respir J 2004; 24: Suppl. 48, 606s Year: 2004
CHF6366: characterisation of the bronchoprotective effect of a novel MABA compound in the experimental bronchospasm model in anaesthetised guinea pigs Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017
The in vitro biology of Compound X – a novel β2 adrenoceptor agonist with a long duration of action Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
Biphasic modulation of adenosine(AR)-induced bronchial responses during chronic caffeine treatment in guinea pigs Source: Eur Respir J 2004; 24: Suppl. 48, 130s Year: 2004
The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
AWD 12-281, a new selective PDE4-inhibitor with a high safety margin: separation of anti-inflammatory and emetic effects in ferrets and domestic pigs Source: Eur Respir J 2002; 20: Suppl. 38, 617s Year: 2002
Pharmacological characterization of indacaterol, a novel 24-hour β2 -agonist, on isolated human bronchus Source: Eur Respir J 2005; 26: Suppl. 49, 216s Year: 2005
The β-adrenoceptor antagonist propranolol induced Ca2+ mobilisation and enhanced contractile responses in guinea pig airways, in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 190s Year: 2002
Effect of aclidinium bromide, a novel long-acting anticholinergic, on salivation, colonic motility and faecal output in different animal models Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008